ProShare Advisors’s Ovid Therapeutics OVID Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,754
| Closed | -$3.98K | – | 2156 |
|
|
2025
Q1 | $3.98K | Sell |
12,754
-3,830
| -23% | -$1.2K | ﹤0.01% | 2078 |
|
|
2024
Q4 | $15.5K | Buy |
16,584
+1,263
| +8% | +$1.18K | ﹤0.01% | 2258 |
|
|
2024
Q3 | $18.1K | Buy |
15,321
+2,956
| +24% | +$3.49K | ﹤0.01% | 2049 |
|
|
2024
Q2 | $9.51K | Sell |
12,365
-3,301
| -21% | -$2.54K | ﹤0.01% | 1838 |
|
|
2024
Q1 | $47.8K | Buy |
15,666
+1,281
| +9% | +$3.91K | ﹤0.01% | 1908 |
|
|
2023
Q4 | $46.3K | Buy |
+14,385
| New | +$46.3K | ﹤0.01% | 1870 |
|
|
2021
Q4 | – | Sell |
-14,511
| Closed | -$49K | – | 2345 |
|
|
2021
Q3 | $49K | Buy |
14,511
+2,328
| +19% | +$7.86K | ﹤0.01% | 1966 |
|
|
2021
Q2 | $48K | Sell |
12,183
-9,306
| -43% | -$36.7K | ﹤0.01% | 2361 |
|
|
2021
Q1 | $86K | Buy |
21,489
+1,156
| +6% | +$4.63K | ﹤0.01% | 2182 |
|
|
2020
Q4 | $47K | Buy |
+20,333
| New | +$47K | ﹤0.01% | 2050 |
|